Erlotinib Tablets

Listing ID #6529936

Get Latest Price

FormTablets
Best Before36 Months from Manufacturing
TreatmentCancer
DosageAs per Doctor's Prescription
StorageCool and Dry Place
Supply Type Supplier
Preferred Buyer Location All over the world

Product Details

A drug used alone to treat certain types of non-small cell lung cancer and with gemcitabine hydrochloride to treat certain types of pancreatic cancer. It is also being studied in the treatment of other types of cancer. Erlotinib hydrochloride blocks a protein called EGFR, which may help keep cancer cells from growing. It is a type of tyrosine kinase inhibitor. Also called CP-358,774, OSI-774, and Tarceva. US Brand Name(s): Tarceva. FDA Approved: Yes

Erlotinib, sold under the brand name Tarceva among others, is a medication used to treat non-small cell lung cancer (NSCLC) and pancreatic cancer. Specifically it is used for NSCLC with mutations in the epidermal growth factor receptor (EGFR) — either an exon 19 deletion (del19) or exon 21 (L858R) substitution mutation — which has spread to other parts of the body. It is taken by mouth.

Erlotinib was approved for medical use in the United States in 2004. It is on the World Health Organization’s List of Essential Medicines.

Use in Cancer

Erlotinib hydrochloride is approved to be used alone or with other drugs to treat:
Non-small cell lung cancer (NSCLC) that is metastatic and has certain EGFR gene mutations.
The use of erlotinib hydrochloride to treat NSCLC that does not have the EGFR gene mutations is no longer FDA-approved.
Pancreatic cancer. It is used with gemcitabine hydrochloride in patients whose disease cannot be removed by surgery, is locally advanced, or has metastasized.
Erlotinib hydrochloride is also being studied in the treatment of other types of cancer.

Company Details

Established in 2016, Medicant Healthcare has secured a noticeable position among the Exporter and service providers of good quality Pharmaceutical Medicines and Cancer Drugs. Our drugs are designed following the FDA norms under the strict supervision of qualified experts. Our product range comprises Ulcerative Colitis, Uterus Cancer, Thyroid Cancer, Prostate Cancer, Pancreatic Cancer, Ovarian Cancer, Lung Cancer, Kidney Cancer, Gastric Cancer, Immunology, and Colorectal Cancer. Known for their fast and long-lasting results, these drugs are rather demanded around the world.

For the secure and hygienic design of the available drugs, we have established a roomy infrastructure, which is further segregated into numerous departments. The departments are capable of advanced machines, which are upgraded according to the present market demands.

A well-maintained warehouse makes sure useful storage of the offered products. According to the vast and trustworthy logistic partners, we bring our products to the customer’s end within the set time frame. Moreover, our drugs are made available at an affordable market cost.

Our revered mentors, Mr. Akhilesh Chaudhary, motivate the team with their rich industry knowledge and experience. The prime focus is on offering a smooth and pressure-free work setting for the employees and has assisted them to give their best. Additionally, they have enabled the company in gaining a strong market stand among the manufacturers and suppliers of excellent quality pharmaceutical medicines and cancer drugs.